SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance.
Jiafeng ChenZheng GaoXiaogang LiYing-Hong ShiZheng TangWeiren LiuXin ZhangAo HuangXuanming LuoQiang GaoGuangyu DingKang SongJian ZhouJia FanXiutao FuZhenbin DingPublished in: Cancer medicine (2022)
These data provided new evidence for the mechanism by which abundant p62 expression promoted ICC progression, suggesting a promising therapeutic target for antimetastatic strategies in patients with ICC.